ID

39668

Descrizione

Proof of Concept Study for Safety and Efficacy of EDP239 in Hepatitis C Subjects; ODM derived from: https://clinicaltrials.gov/show/NCT01856426

collegamento

https://clinicaltrials.gov/show/NCT01856426

Keywords

versioni (1)
  1. 09/02/20 09/02/20 -
Titolare del copyright

See clinicaltrials.gov

Caricato su

9 febbraio 2020

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY 4.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Eligibility Hepatitis C NCT01856426

Inglese

Eligibility Hepatitis C NCT01856426

1 moduli  
Inclusion Criteria
Descrizione

Inclusion Criteria

Alias
UMLS CUI
C1512693
subjects must have chronic genotype-1 hepatitis c virus infection and plasma hcv-rna
Descrizione

Chronic Hepatitis C Genotype

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0524910
UMLS CUI [1,2]
C1533728
≥ 105 iu/ml at the time of screening.
Descrizione

Hepatitis C virus RNA assay Plasma

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C1272251
UMLS CUI [1,2]
C0032105
subjects must have chronic hcv infection as determined by any of the following:
Descrizione

Hepatitis C, Chronic

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0524910
be anti-hcv (+) for at least 6 months per subject history or medical records
Descrizione

Hepatitis C antibody positive Duration

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0281863
UMLS CUI [1,2]
C0449238
an anti-hcv test, viral load, or genotype > 6 months ago
Descrizione

Hepatitis C antibody test | Viral load | Genotype determination

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0201487
UMLS CUI [2]
C1261478
UMLS CUI [3]
C1285573
in the setting of a recent positive anti-hcv test (< 6 months), liver biopsy demonstrating chronicity
Descrizione

Hepatitis C antibody test Positive | Chronicity Biopsy of liver

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0201487
UMLS CUI [1,2]
C1514241
UMLS CUI [2,1]
C0547045
UMLS CUI [2,2]
C0193388
subjects must have il-28b genotype "cc"
Descrizione

IL-28B Genotype

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C1425475
UMLS CUI [1,2]
C1285573
subjects must weigh at least 50 kg to participate in the study, and must have a body mass index (bmi) within the range of 18 - 36 kg/m2. bmi = body weight (kg) / [height (m)]2
Descrizione

Body Weight | Body mass index

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0005910
UMLS CUI [2]
C1305855
Exclusion Criteria
Descrizione

Exclusion Criteria

Alias
UMLS CUI
C0680251
use of other investigational drugs at the time of enrollment, or within 5 half-lives of enrollment, or within 30 days (for small molecules) whichever is longer; or longer if required by local regulations.
Descrizione

Investigational New Drugs

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0013230
previous treatment, including the use of any investigational agents, for the treatment of hcv infection.
Descrizione

Prior Therapy Hepatitis C | Investigational New Drugs

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C1514463
UMLS CUI [1,2]
C0019196
UMLS CUI [2]
C0013230
women of child bearing potential.
Descrizione

Childbearing Potential

Tipo di dati

boolean

Alias
UMLS CUI [1]
C3831118
subjects with il-28b genotype "ct or tt".
Descrizione

IL-28B Genotype

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C1425475
UMLS CUI [1,2]
C1285573
alt γ-gt, and ast must be below 5 x the upper limit of normal (uln).
Descrizione

Alanine aminotransferase measurement | Gamma glutamyl transferase measurement | Aspartate aminotransferase measurement

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0201836
UMLS CUI [2]
C0202035
UMLS CUI [3]
C0201899
serum bilirubin must not exceed uln.
Descrizione

Serum total bilirubin measurement

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1278039
the pt (inr) must be within normal limits.
Descrizione

Prothrombin time assay | International Normalized Ratio

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0033707
UMLS CUI [2]
C0525032
if necessary, laboratory testing may be repeated on one occasion (as soon as possible) prior to randomization, to rule out any laboratory error.
Descrizione

Laboratory Procedure Repeated | Errors Excluded

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0022885
UMLS CUI [1,2]
C0205341
UMLS CUI [2,1]
C0743559
UMLS CUI [2,2]
C0332196
use of drugs that inhibit or induce cyp3a4.
Descrizione

CYP3A4 Inhibitors | CYP3A4 Inducers

Tipo di dati

boolean

Alias
UMLS CUI [1]
C3850053
UMLS CUI [2]
C3850041
Ritorna all'inizio della pagina

Similar models

Eligibility Hepatitis C NCT01856426

1 moduli
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
C1512693 (UMLS CUI)
Chronic Hepatitis C Genotype
Item
subjects must have chronic genotype-1 hepatitis c virus infection and plasma hcv-rna
boolean
C0524910 (UMLS CUI [1,1])
C1533728 (UMLS CUI [1,2])
Hepatitis C virus RNA assay Plasma
Item
≥ 105 iu/ml at the time of screening.
boolean
C1272251 (UMLS CUI [1,1])
C0032105 (UMLS CUI [1,2])
Hepatitis C, Chronic
Item
subjects must have chronic hcv infection as determined by any of the following:
boolean
C0524910 (UMLS CUI [1])
Hepatitis C antibody positive Duration
Item
be anti-hcv (+) for at least 6 months per subject history or medical records
boolean
C0281863 (UMLS CUI [1,1])
C0449238 (UMLS CUI [1,2])
Hepatitis C antibody test | Viral load | Genotype determination
Item
an anti-hcv test, viral load, or genotype > 6 months ago
boolean
C0201487 (UMLS CUI [1])
C1261478 (UMLS CUI [2])
C1285573 (UMLS CUI [3])
Hepatitis C antibody test Positive | Chronicity Biopsy of liver
Item
in the setting of a recent positive anti-hcv test (< 6 months), liver biopsy demonstrating chronicity
boolean
C0201487 (UMLS CUI [1,1])
C1514241 (UMLS CUI [1,2])
C0547045 (UMLS CUI [2,1])
C0193388 (UMLS CUI [2,2])
IL-28B Genotype
Item
subjects must have il-28b genotype "cc"
boolean
C1425475 (UMLS CUI [1,1])
C1285573 (UMLS CUI [1,2])
Body Weight | Body mass index
Item
subjects must weigh at least 50 kg to participate in the study, and must have a body mass index (bmi) within the range of 18 - 36 kg/m2. bmi = body weight (kg) / [height (m)]2
boolean
C0005910 (UMLS CUI [1])
C1305855 (UMLS CUI [2])
Item Group
C0680251 (UMLS CUI)
Investigational New Drugs
Item
use of other investigational drugs at the time of enrollment, or within 5 half-lives of enrollment, or within 30 days (for small molecules) whichever is longer; or longer if required by local regulations.
boolean
C0013230 (UMLS CUI [1])
Prior Therapy Hepatitis C | Investigational New Drugs
Item
previous treatment, including the use of any investigational agents, for the treatment of hcv infection.
boolean
C1514463 (UMLS CUI [1,1])
C0019196 (UMLS CUI [1,2])
C0013230 (UMLS CUI [2])
Childbearing Potential
Item
women of child bearing potential.
boolean
C3831118 (UMLS CUI [1])
IL-28B Genotype
Item
subjects with il-28b genotype "ct or tt".
boolean
C1425475 (UMLS CUI [1,1])
C1285573 (UMLS CUI [1,2])
Alanine aminotransferase measurement | Gamma glutamyl transferase measurement | Aspartate aminotransferase measurement
Item
alt γ-gt, and ast must be below 5 x the upper limit of normal (uln).
boolean
C0201836 (UMLS CUI [1])
C0202035 (UMLS CUI [2])
C0201899 (UMLS CUI [3])
Serum total bilirubin measurement
Item
serum bilirubin must not exceed uln.
boolean
C1278039 (UMLS CUI [1])
Prothrombin time assay | International Normalized Ratio
Item
the pt (inr) must be within normal limits.
boolean
C0033707 (UMLS CUI [1])
C0525032 (UMLS CUI [2])
Laboratory Procedure Repeated | Errors Excluded
Item
if necessary, laboratory testing may be repeated on one occasion (as soon as possible) prior to randomization, to rule out any laboratory error.
boolean
C0022885 (UMLS CUI [1,1])
C0205341 (UMLS CUI [1,2])
C0743559 (UMLS CUI [2,1])
C0332196 (UMLS CUI [2,2])
CYP3A4 Inhibitors | CYP3A4 Inducers
Item
use of drugs that inhibit or induce cyp3a4.
boolean
C3850053 (UMLS CUI [1])
C3850041 (UMLS CUI [2])
Ritorna all'inizio della pagina 

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial